DDInter1855 DDInter1676
Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate.[L8246,L8249,L8252,L8255,L8258,L8261,L8264] Triamcinolone was granted FDA approval on 3 December 1957. In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval - for the treatment of patients with macular
Siponimod, also known as _Mayzent_, by Novartis, is a new drug formulated for the management of Multiple Sclerosis (MS). It was approved by the FDA on March 26, 2019 and by Health Canada on February 20, 2020. This drug is considered a _sphingosine-1-phosphate (S1P) receptor modulator_ and is thought to play a role in suppressing the central nervous system inflammation that is associated with MS [FDA label]. Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system that is chronic and inflammatory, disrupting communication between the brain and other parts of the body. Most patients diagnosed with this illness experience their initial disease symptoms between the age of 20 to 40, often the most productive years of life. Symptoms may include but are not limited to fatigue, gait changes, bowel or bladder dysfunction, abnormal muscle twitching, vision disturbance, and depressing or mood swings. MS is one of the most common causes of neurological disability in young adults and is found to occur more frequently in women than in men.[A176474,L5792]
Triamcinolone {u} (Compound) resembles {v} (Compound) Prednisone
Triamcinolone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Fluoxymesterone
Triamcinolone {u} (Compound) resembles {v} (Compound) Budesonide
Triamcinolone {u} (Compound) treats {v} (Disease) multiple sclerosis
Triamcinolone {u} (Compound) binds {v} (Gene) SERPINA6
Triamcinolone {u} (Compound) upregulates {v} (Gene) CDKN1A
Triamcinolone {u} (Compound) palliates {v} (Disease) brain cancer
Triamcinolone {u} (Compound) is included by {v} (Pharmacologic Class) Corticosteroid Hormone Receptor Agonists
Triamcinolone {u} (Compound) downregulates {v} (Gene) GDF15
Triamcinolone {u} (Compound) causes {v} (Side Effect) Acute coronary syndrome
Triamcinolone (Compound) resembles Prednisone (Compound)
Triamcinolone may cause a moderate interaction that could exacerbate diseases when taken with Fluoxymesterone
Triamcinolone (Compound) resembles Budesonide (Compound)
Triamcinolone (Compound) treats multiple sclerosis (Disease)
Triamcinolone (Compound) binds SERPINA6 (Gene)
Triamcinolone (Compound) upregulates CDKN1A (Gene)
Triamcinolone (Compound) palliates brain cancer (Disease)
Triamcinolone (Compound) is included by Corticosteroid Hormone Receptor Agonists (Pharmacologic Class)
Triamcinolone (Compound) downregulates GDF15 (Gene)
Triamcinolone (Compound) causes Acute coronary syndrome (Side Effect)